Cargando…
Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer
The recent manuscript in New England Journal of Medicine by Antonarakis et al.1 has important clinical implications. This study evaluates mRNA expression of a particular androgen receptor splice variant-7 (AR-V7), in circulating tumor cells (CTCs) from metastatic castrate-resistant prostate cancer (...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430945/ https://www.ncbi.nlm.nih.gov/pubmed/25532583 http://dx.doi.org/10.4103/1008-682X.145069 |